TY - JOUR T1 - GraphGR: A graph neural network to predict the effect of pharmacotherapy on the cancer cell growth JF - bioRxiv DO - 10.1101/2020.05.20.107458 SP - 2020.05.20.107458 AU - Manali Singha AU - Limeng Pu AU - Abd-El-Monsif Shawky AU - Konstantin Busch AU - Hsiao-Chun Wu AU - J. Ramanujam AU - Michal Brylinski Y1 - 2020/01/01 UR - http://biorxiv.org/content/early/2020/05/23/2020.05.20.107458.abstract N2 - Genomic profiles of cancer cells provide valuable information on genetic alterations in cancer. Several recent studies employed these data to predict the response of cancer cell lines to treatment with drugs. Nonetheless, due to the multifactorial phenotypes and intricate mechanisms of cancer, the accurate prediction of the effect of pharmacotherapy on a specific cell line based on the genetic information alone is problematic. High prediction accuracies reported in the literature likely result from significant overlaps among training, validation, and testing sets, making many predictors inapplicable to new data. To address these issues, we developed GraphGR, a graph neural network with sophisticated attention propagation mechanisms to predict the therapeutic effects of kinase inhibitors across various tumors. Emphasizing on the system-level complexity of cancer, GraphGR integrates multiple heterogeneous data, such as biological networks, genomics, inhibitor profiling, and genedisease associations, into a unified graph structure. In order to construct diverse and information-rich cancer-specific networks, we devised a novel graph reduction protocol based on not only the topological information, but also the biological knowledge. The performance of GraphGR, properly cross-validated at the tissue level, is 0.83 in terms of the area under the receiver operating characteristics, which is notably higher than those measured for other approaches on the same data. Finally, several new predictions are validated against the biomedical literature demonstrating that GraphGR generalizes well to unseen data, i.e. it can predict therapeutic effects across a variety of cancer cell lines and inhibitors. GraphGR is freely available to the academic community at https://github.com/pulimeng/GraphGR.Competing Interest StatementThe authors have declared no competing interest. ER -